# Chantal Mathieu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chantal-mathieu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 65,175 |
| Field | Diabetes Management and Research |
| h-index | 124 |
| i10-index | 678 |
| Last Known Institution | KU Leuven |
| OpenAlex ID | https://openalex.org/A5053469409 |
| ORCID iD | https://orcid.org/0000-0002-4055-5233 |
| Works | 1,599 |

## Researcher papers

- [Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycaemia-in-type-2-diabetes-2018-a-consensus-report-by-the/)
- [Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes](https://scholariq.org/papers/insulin-needs-after-cd3-antibody-therapy-in-new-onset-type-1-diabetes/)
- [Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycaemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)
- [Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis](https://scholariq.org/papers/differentiation-of-diabetes-by-pathophysiology-natural-history-and-prognosis/)
- [Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease](https://scholariq.org/papers/association-of-adipose-tissue-inflammation-with-histologic-severity-of/)
- [Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass](https://scholariq.org/papers/four-year-metabolic-outcome-of-a-randomised-controlled-cd3-antibody-trial-in/)
- [Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled/)
- [Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study](https://scholariq.org/papers/effect-of-continuous-glucose-monitoring-on-glycemic-control-acute-admissions-and/)
- [Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial](https://scholariq.org/papers/anti-interleukin-21-antibody-and-liraglutide-for-the-preservation-of-cell/)

## Researcher topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Vitamin D Research Studies](https://scholariq.org/topics/vitamin-d-research-studies-2/)

## Researcher university

- [KU Leuven](https://scholariq.org/institutions/ku-leuven/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
